Associated Papers
The cystic fibrosis V232D mutation inhibits CFTR maturation by disrupting a hydrophobic pocket rather than formation of aberrant interhelical hydrogen bonds.
Loo TW et al.
Biochemical Pharmacology, 2014
Corrector VX-809 stabilizes the first transmembrane domain of CFTR.
Loo TW et al.
Biochemical Pharmacology, 2013
Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M et al.
Scandinavian Journal of Immunology, 2001
Select a paper to view details